These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15132875)
1. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia]. Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875 [TBL] [Abstract][Full Text] [Related]
2. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. Amarapurkar DN; Rane P J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365 [TBL] [Abstract][Full Text] [Related]
3. Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Kinoshita Y; Hashimoto T; Kawamura A; Yuki M; Amano K; Sato H; Adachi K; Sato S; Oshima N; Takashima T; Kitajima N; Abe K; Suetsugu H Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():37-41. PubMed ID: 15943845 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. Seno H; Nakase H; Chiba T Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():32-6. PubMed ID: 15943844 [TBL] [Abstract][Full Text] [Related]
6. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Talley NJ; Tack J; Ptak T; Gupta R; Giguère M Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059 [TBL] [Abstract][Full Text] [Related]
7. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Otaka M; Jin M; Odashima M; Matsuhashi T; Wada I; Horikawa Y; Komatsu K; Ohba R; Oyake J; Hatakeyama N; Watanabe S Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():42-6. PubMed ID: 15943846 [TBL] [Abstract][Full Text] [Related]
8. Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS). Hongo M; Harasawa S; Mine T; Sasaki I; Matsueda K; Kusano M; Hanyu N; Nakada K; Shibata C J Gastroenterol Hepatol; 2012 Jan; 27(1):62-8. PubMed ID: 22004457 [TBL] [Abstract][Full Text] [Related]
9. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials. Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of postprandial discomfort syndrome in the elderly: a multi-centered prospective randomized controlled clinical study]. Wang GS; Xu L; Chen HT; Shi LP; Huang MJ; Xi L; Xu LS; Wang F; Li HY; Li S; Zhang YJ; Tan SY; Hong RT; Lyu NH; Ye M; Gan HT; Liu M; Wu BY; Zhonghua Nei Ke Za Zhi; 2020 Feb; 59(2):117-123. PubMed ID: 32074684 [No Abstract] [Full Text] [Related]
11. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Hallerbäck BI; Bommelaer G; Bredberg E; Campbell M; Hellblom M; Lauritsen K; Wienbeck M; Holmgren LL Aliment Pharmacol Ther; 2002 May; 16(5):959-67. PubMed ID: 11966505 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study: Shanghai Combizym Clinical Cooperative Group. Ran ZH; Yuan YZ; Li ZS; Wang JY; Zong CH; Xie WF; Zheng P; Chen SL; Zhan XB; Chen SY; Xiao SD J Dig Dis; 2009 Feb; 10(1):41-8. PubMed ID: 19236546 [TBL] [Abstract][Full Text] [Related]
14. Mosapride treatment for functional dyspepsia: a meta-analysis. Bang CS; Kim JH; Baik GH; Kim HS; Park SH; Kim EJ; Kim JB; Suk KT; Yoon JH; Kim YS; Kim DJ J Gastroenterol Hepatol; 2015 Jan; 30(1):28-42. PubMed ID: 25041564 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758 [TBL] [Abstract][Full Text] [Related]
16. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease. Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863 [TBL] [Abstract][Full Text] [Related]
18. [The effect of mosapride on quality of life in functional dyspepsia]. Cho YK; Choi MG; Kim SH; Lee IS; Kim SW; Chung IS; Lee SY; Choi SC; Seol SY Korean J Gastroenterol; 2004 Mar; 43(3):160-7. PubMed ID: 15034286 [TBL] [Abstract][Full Text] [Related]
19. Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia. Cho KH; Choi YK; Kang JH; Choi HG; Yong CS; Park YJ Int J Pharm; 2010 Nov; 400(1-2):145-52. PubMed ID: 20826201 [TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled trial of itopride in functional dyspepsia. Holtmann G; Talley NJ; Liebregts T; Adam B; Parow C N Engl J Med; 2006 Feb; 354(8):832-40. PubMed ID: 16495395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]